You just read:

Can-Fite to Present New Clinical Data from Further Analysis of its Clinical Studies of CF101 for the Treatment of Rheumatoid Arthritis and Psoriasis at OneMedForum and Biotech Showcase held in San Francisco, California

News provided by

Can-Fite BioPharma Ltd.

Jan 13, 2014, 07:00 EST